July 14, 2014 1:03 AM ET

Pharmaceuticals

Company Overview of N30 Pharmaceuticals, Inc.

Key Executives for N30 Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Charles H. Scoggin M.D.10 RelationshipsChief Executive Officer and Director69
Tom Sokolowski No RelationshipsChief Financial Officer and Vice President of Finance & Administration--
Janice Troha No RelationshipsExecutive Vice President of Product Development & Regulatory--
Sherif Gabriel Ph.D.No RelationshipsVice President of Research--

N30 Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arnold Snider 95 RelationshipsN30 Pharmaceuticals, Inc.--
Charles H. Scoggin M.D. 10 RelationshipsN30 Pharmaceuticals, Inc.69
Joseph Loscalzo M.D., Ph.D. 105 RelationshipsNitroMed, Inc.62
Augustine Choi 10 RelationshipsN30 Pharmaceuticals, Inc.--
Joseph A. Vita M.D. 10 RelationshipsN30 Pharmaceuticals, Inc.--
View All Board Members

N30 Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Joseph Loscalzo105 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
473.2K
Bonus
555.2K
Total Short Term Compensation
696.7K
Total Value of Options
18.4M
Compensation as of Fiscal Year
N30 Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Angelika Westerwelle Resigns as Managing Director of Karlie Group GmbH
July 10, 2014 2:08 PM ET
Harbinger Group Inc. Announces New Directors
July 08, 2014 9:12 PM ET
Rubberex Corp. M Bhd Appoints Yee Choy Lean as Joint Secretary, Effective July 01, 2014
July 01, 2014 8:50 AM ET
SCA Names Charity Hughes as Vice Pesident of Human Resources, North America
June 26, 2014 12:00 AM ET
SCA Americas Names Dumitrache Martinez as Vice President, Finance
June 26, 2014 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N30 Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.